Abbott Laboratories (ABT)

82.79
NYSE : Health Technology
Prev Close 82.38
Day Low/High 82.03 / 83.32
52 Wk Low/High 65.44 / 88.76
Avg Volume 4.62M
Exchange NYSE
Shares Outstanding 1.77B
Market Cap 145.60B
EPS 1.30
P/E Ratio 50.85
Div & Yield 1.28 (1.51%)

Latest News

Rallying on a Downside Surprise?: Cramer's 'Mad Money' Recap (Thursday 10/17/19)

Rallying on a Downside Surprise?: Cramer's 'Mad Money' Recap (Thursday 10/17/19)

Jim Cramer explains the unexpected: quarterly results are 'not as bad as feared' -- NABAF. It's boosting stocks that, based on the headlines, should really just crumple.

Stocks End Down as Trade War Fears, Weak Retail Sales Overshadow Strong Earnings

Stocks End Down as Trade War Fears, Weak Retail Sales Overshadow Strong Earnings

Stocks finish down as investors divide their attention between strong third-quarter earnings and concerns over weak U.S. retail sales and the ongoing U.S.-China trade war.

Abbott Laboratories Reports Third Quarter Earnings

We believe buyers are coming in following the conclusion of the largely positive earnings call.

Abbott Laboratories Narrows 2019 Profit Guidance After In-Line Q3 Earnings

Abbott Laboratories Narrows 2019 Profit Guidance After In-Line Q3 Earnings

Abbott Laboratories posted third quarter earnings that were largely in-line with Wall Street forecasts Wednesday, but narrowed its full-year profit forecast.

Adding to Abbott Shortly After the Opening Bell

We are buying this early dip on mixed headline numbers.

Dow Futures Slip, Global Stocks Mixed; Brexit Talks, US Earnings Drive Sentiment

Dow Futures Slip, Global Stocks Mixed; Brexit Talks, US Earnings Drive Sentiment

Global stocks traded mixed Wednesday, with modest gains in Asia offset by weaker U.S. equity futures, as investors eyed the final hours of Brexit negotiations between Britain and the EU while awaiting around round of third quarter earnings reports on Wall Street.

Markets Bet on Growth, 3 Month/10 Year Spread, Trading Nvidia: Market Recon

Markets Bet on Growth, 3 Month/10 Year Spread, Trading Nvidia: Market Recon

The Fed is doing this right. Let me repeat... the Fed is not screwing this up.

Abbott Reports Third-Quarter 2019 Results

Abbott Reports Third-Quarter 2019 Results

- Third-quarter sales growth of 5.5 percent; organic sales growth of 7.6 percent

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.

Kinder Morgan Expected to Earn 24 Cents a Share

Kinder Morgan Expected to Earn 24 Cents a Share

Kinder Morgan revenue expected to fall 1.3% to $3.5 billion.

Crown Castle International Expected to Earn 49 Cents a Share

Crown Castle International Expected to Earn 49 Cents a Share

Crown Castle International revenue expected to rise 7.5% to $1.5 billion.

U.S. Bancorp Expected to Earn $1.11 a Share

U.S. Bancorp Expected to Earn $1.11 a Share

U.S. Bancorp revenue expected to rise 2.2% to $5.8 billion.

Progressive Expected to Earn $1.31 a Share

Progressive Expected to Earn $1.31 a Share

Progressive revenue expected to rise 11.3% to $9.6 billion.

DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

Tandem will include Abbott's Libre sensor in its insulin pump.

Comerica Expected to Earn $1.90 a Share

Comerica Expected to Earn $1.90 a Share

Comerica revenue expected to fall 0.1% to $832.4 million.

PNC Financial Services Group Expected to Earn $2.80 a Share

PNC Financial Services Group Expected to Earn $2.80 a Share

PNC Financial Services Group revenue expected to rise 1.3% to $4.4 billion.

CSX Expected to Earn $1.01 a Share

CSX Expected to Earn $1.01 a Share

CSX revenue expected to fall 4.8% to $3 billion.

United Rentals Expected to Earn $5.56 a Share

United Rentals Expected to Earn $5.56 a Share

United Rentals revenue expected to rise 15.8% to $2.5 billion.

Video: AAP Daily Rundown for Tuesday

Jeff fills in for Jim and discusses this morning's earnings from Goldman Sachs, Citigroup, JP Morgan, UnitedHealth Group, and much more!

Abbott Laboratories Gets OK for Added $3 Billion of Stock Buybacks

Abbott Laboratories Gets OK for Added $3 Billion of Stock Buybacks

Abbott Laboratories rises after the medical device company says its board had authorized an additional $3 billion in share repurchases.

Abbott And Tandem Diabetes Care Exploring New Integrated Solutions To Improve Diabetes Management

Abbott And Tandem Diabetes Care Exploring New Integrated Solutions To Improve Diabetes Management

- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes

This Week's Earnings Previews

These 5 companies report between Tuesday and Friday.

Video: AAP Daily Rundown for Monday

Jeff fills in for Jim and discusses this week's earnings of Goldman Sachs, UnitedHealth Group , Abbott Laboratories, and many more!

Abbott And Omada Health Partner To Offer Integrated Digital Health And Coaching Experience For People With Type 2 Diabetes

Abbott And Omada Health Partner To Offer Integrated Digital Health And Coaching Experience For People With Type 2 Diabetes

- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care

Weekly Roundup

Markets finish strong on optimism U.S. trade tensions with China may be easing.

Last Week's Portfolio Changes

We exited one position, initiated another and upgraded several names last week.

Weekly Roundup

A volatile week ends with heightened expectations for at least one more rate cut from the Fed.

Ready to Rally: Cramer's 'Mad Money' Recap (Thursday 10/3/19)

Ready to Rally: Cramer's 'Mad Money' Recap (Thursday 10/3/19)

Jim Cramer says earnings worries are weighing on stocks, but investors should seek out companies whose reports are not as bad as everyone feared they would be.

TheStreet Quant Rating: A (Buy)